Australia backs COVID-19 vaccine waiver

Australia will waive IP protections for COVID-19 vaccines to enable more cost-effective copycat versions to be manufactured in developing countries, in the wake of mounting pressure from human rights groups and governments worldwide.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Omicron variant delays COVID-19 IP waiver debate

29 November 2021 The World Trade Organization has postponed its ministerial conference indefinitely, potentially ending the opportunity for countries to agree an IP waiver for COVID-19 vaccines this year.

Americas

Brazil passes compulsory licence bill for COVID-19 vaccines

12 August 2021 The Brazilian Senate Plenary has approved a bill that will allow President Bolsonaro to waive patent protections for COVID-19 vaccines.

Americas

Costa Rica asks WHO to create voluntary COVID-19 IP pool

26 March 2020 The Costa Rican government has asked the World Health Organization to create a voluntary pool to collect patent rights for technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic.

More on this story

Big Pharma

Omicron variant delays COVID-19 IP waiver debate

Americas

Brazil passes compulsory licence bill for COVID-19 vaccines

12 August 2021 The Brazilian Senate Plenary has approved a bill that will allow President Bolsonaro to waive patent protections for COVID-19 vaccines.

Americas

Costa Rica asks WHO to create voluntary COVID-19 IP pool

More on this story

Big Pharma

Omicron variant delays COVID-19 IP waiver debate

Americas

Brazil passes compulsory licence bill for COVID-19 vaccines

12 August 2021 The Brazilian Senate Plenary has approved a bill that will allow President Bolsonaro to waive patent protections for COVID-19 vaccines.

Americas

Costa Rica asks WHO to create voluntary COVID-19 IP pool